H(2)S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats

Sheng Li Xue Bao. 2008 Apr 25;60(2):221-7.

Abstract

The present study was aimed to study the effect of hydrogen sulfide (H(2)S) on rat myocardial ischemia/reperfusion (I/R) injury and whether the effect is mediated by c-Fos protein expression. Male Sprague-Dawley rats were randomly divided into 4 groups:

Control group: sham treatment; I/R group: the rat anterior descending branch of left coronary artery was occluded for 30 min and then released to allow reperfusion for 60 min; NaHS (exogenous H(2)S donor) groups: the rats were pretreated with NaHS at 2.8 μmol/kg body weight and 14 μmol/kg body weight (i.v.), respectively, before I/R treatment. Hemodynamics (LVSP, LV±dp/dt(max)) and electrocardiogram (ECG, lead II) were monitored continuously with multi-channel physiological signal analysis system after reperfusion. Myocardial infarct size was measured using triphenyltetrazolium chloride (TTC) staining. H(2)S concentration in the plasma was determined with a spectrophotometer. Morphological and ultrastructural changes in myocardial tissue were evaluated by HE staining and by a transmission electron microscope. The evaluation of c-Fos protein expression in myocardial tissue was performed by immunohistological staining. The results showed that H(2)S concentration in rat plasma in I/R group was significantly decreased compared with that in the control group [(30.32±5.26) vs (58.28±7.86) μmol/L, P<0.05]. NaHS at 2.8 and 14 μmol/kg body weight reduced the changes in LVSP, LV±dp/dt(max) in rat myocardium induced by I/R injury. The values of LVSP, +dp/dt(max) and -dp/dt(max) at 60 min during myocardial reperfusion were enhanced from (75.93±1.10)%, (66.27±4.78)% and (66.01±4.79)% in I/R group to (84.34±2.24)%, (76.38±1.93)% and (75.47±5.29)% in 2.8 μmol/kg body weight NaHS group (P<0.05, P<0.01, n=6), (88.40±2.88)%, (80.10±2.09)% and (80.48±6.20)% in 14 μmol/kg body weight NaHS group (P<0.01, n=6), respectively. Compared with that in 2.8 μmol/kg body weight NaHS group, the enhancing effect was more prominent in 14 μmol/kg body weight NaHS group. NaHS at 14 μmol/kg body weight markedly alleviated the injury in morphological changes and decreased c-Fos protein expression in myocardial tissue compared with that in I/R group (0.20±0.06 vs 0.32±0.10, P<0.05). These results suggest that H(2)S protects myocardium against I/R injury and this protective effect may be related to the down-regulation of c-Fos protein expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology*
  • Coronary Vessels
  • Down-Regulation
  • Hemodynamics
  • Hydrogen Sulfide / pharmacology*
  • Male
  • Myocardial Infarction / pathology
  • Myocardial Reperfusion Injury / drug therapy*
  • Myocardial Reperfusion Injury / metabolism
  • Myocardium / metabolism
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Sulfides / pharmacology

Substances

  • Cardiotonic Agents
  • Proto-Oncogene Proteins c-fos
  • Sulfides
  • sodium bisulfide
  • Hydrogen Sulfide